Tender detail
Medicinal Products IV (2027–2028)
Summary
The Masaryk Memorial Cancer Institute is procuring medicinal products in eight lots for delivery in Brno from 2027 to 2028. The lots cover palonosetron combination (3,000 packs), nab-paclitaxel (3,600), trastuzumab (2,000), bevacizumab (7,600), pegfilgrastim (1,000), enzalutamide (3,800), denosumab (2,000) and trametinib (600 packs of 2 mg and 570 packs of 0.5 mg). The estimated value including reserved changes is CZK 615.9 million excluding VAT.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.